Abstract:Abstract Background: Variation in genes implicated in homocysteine and lipid metabolism systems may influence antidepressant response. This study was aimed to investigate how the MTHFR, ApoE and ApoA4 polymorphisms determine this response to treatment. Methods: A total of 281 Han Chinese patients received a single antidepressant drug (SSRI or SNRI) for at least 6 weeks. The Hamilton Depression Rating Scale (HDRS-17) was used to evaluate the severity of depressive symptoms and the therapeutic effects of the drug administered. Eight single nucleotide polymorphisms (SNPs) of MTHFR, ApoE and ApoA4 genes were detected using gene chips. Differences in clinical variables between the responders and non-responders, as well as between remission and non-remission groups, were examined using the independent samples t test and Pearson’s χ2 test. In addition, the associations of single loci and haplotypes with treatment response were analyzed. Results: Haplotype (C-A) in MTHFR (rsl801133 and rs1801131) was significantly associated with better antidepressant response in the 8-week antidepressant group overall (P = 0.0007), and in the male subgroup (P = 0.003), and SNRI subgroup (P = 0.001). The ApoE rs405509 C allele was significantly associated with worse antidepressant response in the 6-week male subgroup (P = 0.004), while the 405509 AA genotype was associated with better antidepressant efficacy in the 6-week group overall (P = 0.006) and male subgroup (P = 0.002). Haplotype (G-A) in APOE (rs7412 and rs405509) was significantly associated with better antidepressant response in 6-week male subgroup (P = 0.003), G-C haplotype was associated with better response in 6-week SNRI subgroup；APOA4 rs5092 G allele was associated with worse antidepressant response in 6-weeks male subgroup (P = 0.037), SNRIs subgroup (P = 0.097) and 8-weeks female subgroup (P = 0.045)；APOA4 rs5092 GG genotype was associated with worse antidepressant efficacy in 6-week SNRI subgroup (P = 0.008). Conclusions: The haplotype in MTHFR (rs1801131-rs1801133) C-A type was associated with better antidepressant efficacy, especially in males and in patients using SNRIs. The efficacy of antidepressants may be better in ApoE rs405509 A allele and AA genotype carriers, but worse in ApoA4 rs5092 G allele and GG genotype carriers.

Effect of ABCB1 gene polymorphisms on efficacy of antidepressants:a Meta-analysis

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association Of Abcb1 Polymorphisms And Ulcerative Colitis Susceptibility

ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy

Influence of GNB3 C825T Polymorphism on the Efficacy of Antidepressants in the Treatment of Major Depressive Disorder: A Meta-Analysis.

ABCB1 Gene is Associated with Clinical Response to SNRIs in a Local Chinese Han Population.

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

ABCB6, ABCB1 and ABCG1 Genetic Polymorphisms and Antidepressant Response of SSRIs in Chinese Depressive Patients.

Relationship between ABCB1 gene polymorphisms and major depressive disorder

Case-Control Association Study of Abcb1 Gene and Major Depressive Disorder in A Local Chinese Han Population

Association between ABCB1 C3435T Polymorphism and Statins Effectiveness Among Chinese Population:A Meta-Analysis

Association between ABCB1 polymorphisms and haplotypes and Alzheimer’s disease: a meta-analysis

Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response

Association Between 5-HTR1A Gene C-1019G Polymorphism and Antidepressant Response in Patients with Major Depressive Disorder: A Meta-Analysis

Results from a Portuguese Major Depressive Disorder Cohort

Association Study of GABRB2 gene and antidepressant response to SNRI in patients with major depression.

Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer.

Brain-derived Neurotrophic Factor’s Val66Met and C270T Polymorphisms Influence Citalopram/Escitalopram Response in Chinese Patients with Major Depressive Disorder

Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response]

The association of escitalopram efficacy with CYP2C19 and ABCB1 gene polymorphisms

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated with Antidepressant Efficacy in Major Depressive Disorder